Fulcrum Therapeutics, Inc. SEC filings FULC

Fulcrum Therapeutics, Inc. has 520 filings in SEC EDGAR's recent list, going back to Jul 25, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 30, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 17, 2026 (material agreement, unregistered share sale, change in control, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Fulcrum Therapeutics, Inc. SEC filings
Form Description Filed Period
EFFECT Filing Nov 4, 2026 —
424B3 Prospectus Nov 4, 2026 —
S-4/A Filing Nov 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 28, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
S-4/A Filing Oct 20, 2026 —
S-4/A Filing Oct 8, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
S-4 Registration for a merger or exchange Sep 2, 2026 —
425 Filing Aug 17, 2026 —
425 Filing Aug 17, 2026 —
425 Filing Aug 17, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
Aug 17, 2026 Aug 16, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Officer or director change
Aug 10, 2026 Aug 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 3, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
4 Insider transaction Jul 20, 2026 Jul 16, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 15, 2026 —
4 Insider transaction Jul 15, 2026 Jul 13, 2026
3 Initial insider ownership Jul 15, 2026 Jul 13, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 25, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 25, 2026 —
8-K Current report
Shareholder vote results
Jun 25, 2026 Jun 24, 2026
8-K Current report
Officer or director change
Jun 11, 2026 Jun 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 10, 2026 —
8-K Current report
Exit or restructuring costs, Other events
Jun 4, 2026 May 31, 2026
8-K Current report
Other events
Jun 1, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 1, 2026 Apr 23, 2026
3 Initial insider ownership May 1, 2026 Apr 23, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 24, 2026
10-Q Quarterly report Apr 27, 2026 Mar 31, 2026
8-K Current report
Agreement ended, Results of operations, Officer or director change
Apr 27, 2026 Apr 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
S-8 Employee stock plan registration Feb 24, 2026 —
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4/A Filing Feb 4, 2026 Jan 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
8-K Current report
Material agreement, Other events
Dec 11, 2025 Dec 10, 2025
424B5 Prospectus supplement Dec 11, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 10, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
FWP Free writing prospectus Dec 10, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
424B5 Prospectus supplement Dec 8, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2025 Dec 8, 2025
4 Insider transaction Nov 21, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
8-K Current report
Regulation FD disclosure
Aug 28, 2025 Aug 28, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Jul 29, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Jul 29, 2025 Jul 29, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
8-K Current report
Shareholder vote results
Jun 27, 2025 Jun 26, 2025
4 Insider transaction May 9, 2025 May 8, 2025
DEFR14A Filing May 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 2, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Apr 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
8-K Current report
Agreement ended
Mar 4, 2025 Feb 26, 2025
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2025 —
4 Insider transaction Jan 28, 2025 Jan 24, 2025
4 Insider transaction Jan 28, 2025 Jan 24, 2025
4 Insider transaction Jan 28, 2025 Jan 24, 2025
4 Insider transaction Jan 28, 2025 Jan 24, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 6, 2025 —
8-K Current report
Agreement ended
Dec 23, 2024 Dec 18, 2024
SC 13G Ownership over 5% (passive) Dec 6, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 14, 2024 Nov 12, 2024
3 Initial insider ownership Nov 14, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Officer or director change
Nov 12, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G Ownership over 5% (passive) Oct 21, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 7, 2024 —
8-K Current report
Exit or restructuring costs
Sep 24, 2024 Sep 24, 2024
3 Initial insider ownership Sep 23, 2024 Sep 12, 2024
SC 13G Ownership over 5% (passive) Sep 20, 2024 —
SC 13G/A Amended ownership over 5% (passive) Sep 16, 2024 —
8-K Current report
Other events
Sep 12, 2024 Sep 12, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 23, 2024 —
4 Insider transaction Aug 23, 2024 Aug 21, 2024
8-K Current report
Unregistered share sale
Aug 22, 2024 Aug 21, 2024
S-8 Employee stock plan registration Jul 31, 2024 —
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 31, 2024 Jul 31, 2024
4 Insider transaction Jul 8, 2024 Jul 3, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
3 Initial insider ownership Jun 18, 2024 Jun 17, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2024 Jun 17, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Material agreement, Results of operations
May 13, 2024 May 11, 2024
4 Insider transaction May 9, 2024 May 7, 2024
EFFECT Filing Apr 25, 2024 —
CORRESP Letter to the SEC Apr 24, 2024 —
ARS Annual report to shareholders Apr 19, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 19, 2024 —
DEF 14A Proxy statement Apr 19, 2024 Jun 17, 2024
4 Insider transaction Mar 20, 2024 Mar 18, 2024
3 Initial insider ownership Mar 20, 2024 Mar 18, 2024
4 Insider transaction Mar 8, 2024 Mar 8, 2024
144 Notice of proposed sale Mar 8, 2024 —
4 Insider transaction Mar 5, 2024 Mar 4, 2024
UPLOAD Letter from the SEC Mar 1, 2024 —
S-8 Employee stock plan registration Feb 27, 2024 —
S-3 Shelf registration Feb 27, 2024 —
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
4 Insider transaction Jan 30, 2024 Jan 26, 2024
4 Insider transaction Jan 30, 2024 Jan 26, 2024
4 Insider transaction Jan 30, 2024 Jan 26, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Officer or director change
Oct 2, 2023 Sep 28, 2023
8-K Current report
Regulation FD disclosure
Aug 22, 2023 Aug 22, 2023
4 Insider transaction Aug 9, 2023 Aug 7, 2023
3 Initial insider ownership Aug 9, 2023 Aug 7, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations, Officer or director change
Aug 3, 2023 Aug 2, 2023
8-K Current report
Material agreement
Jul 10, 2023 Jul 5, 2023
SC 13G/A Amended ownership over 5% (passive) Jul 7, 2023 —
3 Initial insider ownership Jul 3, 2023 Jul 1, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
10-K/A Amended annual report Jun 26, 2023 Dec 31, 2022
10-K/A Amended annual report Jun 26, 2023 Dec 31, 2021
10-K/A Amended annual report Jun 23, 2023 Dec 31, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
FULC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1680581

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.